GR3027
产品编号: DC11090
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
GR3027（Golexanolone）是一种GABA-a受体调节类固醇拮抗剂，可选择性拮抗别孕烯醇酮和THDOC等神经甾体对GABAA受体的增强活化；抑制α1β2γ2L受体29±5%的THDOC增强GABA反应，不拮抗GABA对GABAA受体的作用；在用于不同受体的特定条件下，α1β2γ2LGABAA受体的IC50=250nM，α5β3γ2LGABAA受体的IC50=350nM；恢复慢性高氨血症和肝性脑病大鼠的空间学习和运动协调。睡眠障碍2期临床
| Cas No.: |
2089238-18-4 |
| 名称: |
(17E)-3α-ethynyl-17-(hydroxyimino)-5α-androstan-3β-ol |
| 别名: |
GR-3027;Golexanolone |
| SMILES: |
C[C@]12CC[C@](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]\4([C@H]3CC/C4=N\O)C)(C#C)O |
| 分子式: |
C21H31NO2 |
| 分子量: |
|
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
GR3027 (Golexanolone) is a GABA-A receptor modulating steroid antagonist that selectively antagonizes the enhanced activation of GABAA receptors by neurosteroids such as allopregnanolone and THDOC; inhibits α1β2γ2L receptor 29 ± 5% of THDOC enhancement of the GABA response, does not antagonize the effect of GABA at the GABAA receptor; during the specific conditions used for the different receptors, IC50=250 nM for the α1β2γ2L GABAA receptor and 350 nM for the α5β3γ2L GABAA receptor; restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy. |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
COA
| LOT NO. |
DOWNLOAD |
|
|
| 2018-0101 |
|
询盘
